Metabolism-Based Gene Differences in Neurons Expressing Hyperphosphorylated AT8− Positive (AT8+) Tau in Alzheimer’s Disease

• Published in: ASN neuro Vol. 13; p. 17590914211019443
• Main Authors: York, Audra, Everhart, Angela, Vitek, Michael P., Gottschalk, Kirby W., Colton, Carol A.
• Format: Journal Article
• Language: English
• Published: Los Angeles, CA SAGE Publications 2021; Sage Publications Ltd; Taylor & Francis
• Subjects: Adaptation; Alzheimer Disease - genetics; Alzheimer's disease; Apolipoprotein E4; Autopsy; Female; Gene expression; Genotypes; Humans; Immunohistochemistry; Lasers; Male; Metabolic pathways; Metabolism; Methionine; Neurodegenerative diseases; Neurons; Neurons - metabolism; Original Paper; Phosphorylation; Tau protein; tau Proteins - genetics; tau Proteins - metabolism; brain metabolism; APOE and sex based changes; differential gene expression; hyperphosphorylated tau; radical s-adenosyl domain 1
• ISSN: 1759-0914; 1759-0914
• DOI: 10.1177/17590914211019443

Metabolic adaptations in the brain are critical to the establishment and maintenance of normal cellular functions and to the pathological responses to disease processes. Here, we have focused on specific metabolic pathways that are involved in immune-mediated neuronal processes in brain using isolated neurons derived from human autopsy brain sections of normal individuals and individuals diagnosed as Alzheimer’s disease (AD). Laser capture microscopy was used to select specific cell types in immune-stained thin brain sections followed by NanoString technology to identify and quantify differences in mRNA levels between age-matched control and AD neuronal samples. Comparisons were also made between neurons isolated from AD brain sections expressing pathogenic hyperphosphorylated AT8- positive (AT8+) tau and non-AT8+ AD neurons using double labeling techniques. The mRNA expression data showed unique patterns of metabolic pathway expression between the subtypes of captured neurons that involved membrane based solute transporters, redox factors, and arginine and methionine metabolic pathways. We also identified the expression levels of a novel metabolic gene, Radical-S-Adenosyl Domain1 (RSAD1) and its corresponding protein, Rsad1, that impact methionine usage and radical based reactions. Immunohistochemistry was used to identify specific protein expression levels and their cellular location in NeuN+ and AT8+ neurons. APOE4 vs APOE3 genotype-specific and sex-specific gene expression differences in these metabolic pathways were also observed when comparing neurons from individuals with AD to age-matched individuals.